• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Cardiology

Hypertension in adolescence associated with end-stage renal disease

byJames EnglandandAnees Daud
March 5, 2019
in Cardiology, Chronic Disease, Nephrology, Pediatrics, Public Health, Urology
Reading Time: 2 mins read
Share on FacebookShare on TwitterShare on LinkedIn

1. In this retrospective cohort study from Israel, hypertension at the age of 16-19 years old was linked with later-life end stage renal disease (ESRD).

2. The association between adolescent hypertension and ESRD remained after accounting for co-morbid conditions such as obesity, and after excluding those with severe hypertension.

Evidence Rating Level: 3 (Average)       

Study Rundown: Hypertension is a common risk factors for the development of end-stage renal disease (ESRD). The effect of non-malignant hypertension among youth on later life ESRD is not known. This study was a retrospective cohort analysis of Israeli military recruits which evaluated the impact of hypertension noted between the ages of 16-19 years on the risk of developing ESRD. The study found that hypertension in this age group increased the risk of ESRD nearly two-fold, even after adjusting for known confounders including obesity, sex, and sociodemographic variables.

The main strengths of this study included the confirmation of hypertension based on repeated blood pressure measurements, and large population of young male and female participants. The main limitations of the study include the lack of blood pressure data between the initial evaluation time and diagnosis of ESRD, and lack of evaluation of chronic kidney disease that was not end stage.

Click to read the study in JAMA Internal Medicine

RELATED REPORTS

Telehealth yields modest improvements in diabetes outcomes 

An intradialytic exercise intervention did not improve dialysis adequacy

Relevant Reading: Associations of risk factors in childhood with arterial stiffness 26 years later: the Hanzhong adolescent hypertension cohort

FDA approvedFor hypertension: Baxfendy (baxdrostat), May 15, 2026→

In-Depth [retrospective cohort]: This study included adolescents aged 16 to 19 years who were evaluated by the Israel Defense Forces regional recruitment centers prior to military service between 1967 and 2013. The cohort was linked to the ESRD registry of the Israel Ministry of Health. Participants were excluded if they were deceased prior to the start of the ESRD registry (1990), had baseline kidney disease or disease known to affect kidney function (diabetes, SLE, vasculitis, etc), or had secondary hypertension. Hypertension was defined as mean blood pressure greater than 140/90 mmHg, based on 10 consecutive BP measurements.

Of the 2,658,238 participants included in the study, 7997 (0.3%) had a diagnosis of essential hypertension. After a median follow up of 19.6 years, 2189 individuals developed ESRD. Adolescent hypertension was associated with an increased risk of ESRD (HR 5.07; 95% CI, 3.73-6.88), After adjusting for known covariates including obesity and sociodemographic variables, the association remained (HR 1.98; 95% CI, 1.42-2.77).

Image: CC/Wiki

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: dialysishypertensionrenal failure
Previous Post

Social media marketing increases children’s consumption of unhealthy, but not healthy snacks

Next Post

Study does not support use of low-dose aspirin after prostate cancer diagnosis

RelatedReports

Diabetes collage: a lidded sugar bowl inside a blue paper circle, with a whole apple and a bunch of leafy greens
Chronic Disease

Telehealth yields modest improvements in diabetes outcomes 

June 22, 2026
Dialysis collage: an older woman in a floral blouse, engraved kidneys, a dialyzer with clear tubing and a pedal exerciser
Chronic Disease

An intradialytic exercise intervention did not improve dialysis adequacy

May 18, 2026
Transthoracic echocardiography can rule out endocarditis in low-risk bacteremic patients
Weekly Rewinds

2 Minute Medicine Rewind May 18, 2026

May 18, 2026
No difference in mortality for intensive versus standard reduction in blood pressure in intracerebral hemorrhage: The ATACH-2 trial
Emergency

Early control of systolic blood pressure following intracerebral hemorrhage may improve functional recovery

March 24, 2026
Next Post

Study does not support use of low-dose aspirin after prostate cancer diagnosis

#VisualAbstract: Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease

#VisualAbstract: Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease

#VisualAbstract: Duration of Initial Empirical Antibiotic Therapy and Outcomes in Very Low Birth Weight Infants

#VisualAbstract: Duration of Initial Empirical Antibiotic Therapy and Outcomes in Very Low Birth Weight Infants

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Ivonescimab plus chemotherapy produced major and complete pathological responses in resectable NSCLC in a phase II study
  • Medicaid status, race and ethnicity are independently associated with increased odds of severe maternal morbidity
  • Artificial intelligence-generated pre-visit summaries improved communication outcomes in neurosurgical consultations
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.